F. R. Sharipov

4 ta ish

Tashkent Pediatric Medical Institute

1. Effectiveness of cytoflavin in patients with high risk development of cerebrovascular diseases.

   Y. N. Madzhidova, Bakhodir Yusupaliev, F. R. Sharipov +2

   MaqolaNeurological Disorders and TreatmentsClinical Medicine (Russian Journal)20202 iqtibos

   ABIABI:AkademIndex/openalex/2020.article.001153

2. Neuroprotective therapy in chronic cerebrovascular diseases

   O. V. Kim, Yo. N. Madzhidova, F. R. Sharipov

   MaqolaNeurological Disorders and TreatmentsRussian neurological Journal20210 iqtibos

   ABIABI:AkademIndex/openalex/2021.article.002398

3. Dynamics of neurocognitive indicators against the background of neuroprotective therapy of vertebrobasilar insufficiency with cerebral venous discirculation symptoms

   O. V. Kim, Ya. N. Madjidova, F. R. Sharipov

   MaqolaNeurological Disorders and TreatmentsAntibiot Khimioter = Antibiotics and Chemotherapy20220 iqtibos

   ABIABI:AkademIndex/openalex/2022.article.001553

4. Efficacy and Safety Of D-, L-Hopanthenic Acid (Pantogam Active) In the Correction of Cognitive and Emotional Disorders in Patients with Arterial Hypertension

   Y.N. Madjidova, G.O. Toshulatova, F. R. Sharipov

   MaqolaNeurological Disorders and TreatmentsInternational journal of modern medicine20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.010182